Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)

Aryl Hydrocarbon Receptor (AHR) is an ubiquitous basic helix-loop-helix transcription factor, which is ligand-activated and involved in numerous biological processes including cell division, cell quiescence and inflammation. It has been shown that AHR is involved in normal hematopoietic progenitor p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentil, Melanie, Hugues, Patricia, Desterke, Christophe, Telliam, Gladys, Sloma, Ivan, Souza, Lucas E. B., Baykal, Seda, Artus, Jerome, Griscelli, Frank, Guerci, Agnes, Johnson-Ansah, Hyacinthe, Foudi, Adlen, Bennaceur-Griscelli, Annelise, Turhan, Ali G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084853/
https://www.ncbi.nlm.nih.gov/pubmed/30091999
http://dx.doi.org/10.1371/journal.pone.0200923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084853/
https://www.ncbi.nlm.nih.gov/pubmed/30091999
http://dx.doi.org/10.1371/journal.pone.0200923

Ejemplares similares